Number of the records: 1  

Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data

  1. 1.
    SYSNO ASEP0154801
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JOstatní články
    TitleCytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data
    Author(s) Říhová, Blanka (MBU-M) RID
    Strohalm, Jiří (UMCH-V)
    Prausová, J. (CZ)
    Kubáčková, K. (CZ)
    Jelínková, Markéta (MBU-M)
    Rozprimová, L. (CZ)
    Šírová, Milada (MBU-M) RID, ORCID
    Plocová, Daniela (UMCH-V)
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Šubr, Vladimír (UMCH-V) RID, ORCID
    Mrkvan, Tomáš (MBU-M)
    Kovář, Marek (MBU-M) RID, ORCID
    Ulbrich, Karel (UMCH-V) RID
    Source TitleJournal of Controlled Release. - : Elsevier - ISSN 0168-3659
    Roč. 91, - (2003), s. 1-16
    Number of pages17 s.
    Languageeng - English
    CountryNL - Netherlands
    Keywordshpma ; human immunoglobulin ; targeted therapy
    Subject RIVEE - Microbiology, Virology
    R&D ProjectsGA305/02/1425 GA ČR - Czech Science Foundation (CSF)
    IBS5020101 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    IAA4050201 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    GA310/99/P020 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z4050913 - UMCH-V
    AV0Z5020903 - MBU-M
    AnnotationAn N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier containing doxorubicin and human immunoglobulin as an actively passively targeting moiety was used in four patients with generalized breast cancer resistant to standard cytotoxic chemotherapy.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2004

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.